Advertisement
Screener

ABSCI CORP (ABSI) EBITDA

ABSCI CORP (ABSI) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$31.46M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$28.12M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$28.21M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$27.31M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$31.46M(m)(m)(m)-9893.71%$1.00K*-$27.56M*(m)$22.62M$9.16M$40.00K
2026-03-31Reported-$28.12M(m)(m)(m)-13078.14%$30.00K-$26.31M(m)$19.27M$9.06M$18.00K
2025-12-31Reported-$28.21M(m)(m)(m)-4340.46%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$27.31M(m)(m)(m)-7225.40%$962.00K*-$25.03M*(m)$19.25M$8.44M$104.00K
2025-06-30Reported-$28.39M(m)(m)(m)-4788.03%$223.00K*-$16.87M*(m)$20.46M$8.53M$131.00K
2025-03-31Reported-$24.66M(m)(m)(m)-2091.35%$25.00K-$21.84M(m)$16.36M$9.47M-$4.00K
2024-12-31Reported-$26.54M(m)(m)(m)-3990.98%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$25.54M(m)(m)(m)-1501.47%$48.00K*-$20.73M*(m)$17.98M$9.26M$37.00K
2024-06-30Reported-$23.34M(m)(m)(m)-1837.56%$333.00K*-$16.84M*(m)$15.26M$9.35M$0.00
2024-03-31Reported-$20.08M(m)(m)(m)-2236.30%$0.00-$17.86M(m)$12.24M$8.74M$12.00K
2023-12-31Reported-$21.26M(m)(m)(m)-6288.46%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$19.79M(m)(m)(m)-2659.95%$307.00K*-$10.36M*(m)$11.03M$9.51M$34.00K
2023-06-30Reported-$39.49M(m)(m)(m)-1172.85%$256.00K*-$19.23M*(m)$12.11M$9.41M$11.00K
2023-03-31Reported-$20.98M(m)(m)(m)-1653.35%$280.00K-$20.12M(m)$12.66M$9.59M$7.00K
2022-12-31Reported-$17.51M(m)(m)(m)-1220.00%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$24.56M(m)(m)(m)-1225.70%$4.87M*-$19.04M*(m)$15.53M$11.41M-$312.00K
2022-06-30Reported-$25.75M(m)(m)(m)-4048.11%$3.89M*-$22.58M*(m)$16.24M$10.51M-$270.00K
2022-03-31Reported-$25.9M(m)(m)(m)-5704.19%$6.86M-$21.15M(m)$15.83M$10.89M$621.00K
2021-12-31Reported-$23.5M(m)(m)(m)-2161.64%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$18.92M(m)(m)(m)-1361.44%$5.62M*-$21.75M*(m)$10.73M$9.73M-$1.70M
2021-06-30Reported-$15.49M(m)(m)(m)-2616.72%$17.75M*-$14.49M*(m)$11.04M$5.18M-$5.62M
2021-03-31Reported-$10.67M(m)(m)(m)-1135.32%$6.36M-$7.29M(m)$7.05M$4.68M-$477.00K
2020-12-31Reported-$4.28M(m)(m)(m)-198.89%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$3.03M(m)(m)(m)-328.96%$735.00K*-$2.71M*(m)$2.69M$1.26M$0.00
2020-06-30Reported-$2.55M(m)(m)(m)-451.95%(m)(m)(m)$2.25M$861.00K$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$108.58M(m)(m)(m)-3877.68%$1.11M-$92.92M(m)$81.42M$35.06M$69.00K
2024-12-31Reported-$95.5M(m)(m)(m)-2106.29%$404.00K-$72.40M(m)$63.86M$36.17M$70.00K
2023-12-31Reported-$101.52M(m)(m)(m)-1775.38%$860.00K-$64.64M(m)$48.07M$37.83M$100.00K
2022-12-31Reported-$93.71M(m)(m)(m)-2069.18%$16.18M-$81.34M(m)$58.91M$40.55M-$461.00K
2021-12-31Reported-$68.58M(m)(m)(m)-1710.75%$38.05M-$60.60M(m)$44.59M$28.78M-$8.90M
2020-12-31Reported-$12.17M(m)(m)(m)-295.60%$2.18M-$10.97M(m)$11.45M$5.50M$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14